| Particulars (Rupees in Crores.) | Sept-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sept-2024 |
|---|---|---|---|---|---|
Gross Sales | 960.7 | 871.6 | 796.9 | 772.4 | 777.3 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 960.7 | 871.6 | 796.9 | 772.4 | 777.3 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 4.2 | 7.1 | 15.3 | 17.8 | 5 |
Total Income | 964.9 | 878.7 | 812.2 | 790.2 | 782.3 |
Total Expenditure | 757 | 679 | 598.9 | 585.2 | 559.2 |
PBIDT | 207.9 | 199.7 | 213.3 | 205 | 223.1 |
Interest | 45 | 32.6 | 26.7 | 25.7 | 19.9 |
PBDT | 162.9 | 167.1 | 186.6 | 179.3 | 203.2 |
Depreciation | 66.1 | 53.4 | 52.6 | 44.7 | 41 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 37.7 | 32.4 | 35.7 | 35.3 | 44.8 |
Deferred Tax | -12.9 | -3.7 | -7.8 | 6.8 | -3.3 |
Reported Profit After Tax | 72 | 85 | 106.1 | 92.5 | 120.7 |
Minority Interest After NP | 5.1 | 6.4 | 4.3 | 3.8 | 13.3 |
Net Profit after Minority Interest | 66.9 | 78.6 | 101.8 | 88.7 | 107.4 |
Extra-ordinary Items | -0.3 | 0 | 7.92 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 67.2 | 78.6 | 93.88 | 88.7 | 107.4 |
EPS (Unit Curr.) | 1.67 | 1.96 | 2.54 | 2.22 | 2.68 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 80 | 80 | 80 | 80 | 80 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 21.64 | 22.91 | 26.76 | 26.54 | 28.7 |
PBDTM(%) | 16.95 | 19.17 | 23.41 | 23.21 | 26.14 |
PATM(%) | 7.49 | 9.75 | 13.31 | 11.97 | 15.52 |
Here are some of the stocks that may see significant price movement today: GIC Re, GSK Pharma, Godfrey Philips, etc.
It has entered into a share purchase agreement to acquire a 100% equity stake in Chalasani Hospitals Pvt Ltd.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.